Pureos Bioventures

Switzerland
cb
Firm Location:Switzerland • Basel, Switzerland • Zurich, Switzerland
Investor Firms That Co-Invest with Pureos Bioventures
HealthCapWellington PartnersPfizer Venture InvestmentsKurma PartnersSanofi VenturesAndera PartnersAdjuvant Capital4BIO CapitalAdvent Life SciencesEarlybird Venture CapitalNorwest Venture PartnersMPM Capital
Pureos Bioventures Team
Photo of Klaus Breiner, Managing Director at Pureos Bioventures
Klaus Breiner
Pureos Bioventures·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Switzerland
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A)
to see your intro paths to Klaus
Photo of Ximing Ding, Associate at Pureos Bioventures
Ximing Ding
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Zurich (Switzerland)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)
to see your intro paths to Ximing
Photo of Dominik Escher, Managing Partner at Pureos Bioventures
Dominik Escher
Pureos Bioventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Zurich (Switzerland)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A)
to see your intro paths to Dominik
Photo of Veronica Gambillara Fonck, Partner at Pureos Bioventures
Veronica Gambillara Fonck
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Zurich (Switzerland)
to see your intro paths to Veronica
Photo of Dragan Grabulovski, Venture Partner at Pureos Bioventures
Dragan Grabulovski
Pureos Bioventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Zurich (Switzerland)
to see your intro paths to Dragan
Photo of Anne Grahl, Analyst at Pureos Bioventures
Anne Grahl
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Switzerland
Investors in BioTech (Seed), Investors in BioTech (Series A)
to see your intro paths to Anne
Photo of Martin Münchbach, Managing Partner at Pureos Bioventures
Martin Münchbach
Pureos Bioventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Zurich (Switzerland)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A)
to see your intro paths to Martin
Photo of Lars Nieba, Venture Partner at Pureos Bioventures
Lars Nieba
Pureos Bioventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Basel (Switzerland)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)
to see your intro paths to Lars